Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China flag China · Delayed Price · Currency is CNY
21.88
+0.34 (1.58%)
Feb 3, 2026, 3:00 PM CST

SHA:600285 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
3,7803,4983,3072,9982,6902,328
Other Revenue
2.732.733.983.443.483.44
3,7833,5013,3113,0022,6942,332
Revenue Growth (YoY)
6.15%5.72%10.31%11.45%15.52%8.09%
Cost of Revenue
735.96848.37888.53837.53707.97547.68
Gross Profit
3,0472,6522,4232,1641,9861,784
Selling, General & Admin
2,0301,7621,6751,6081,4831,342
Research & Development
161.64131.53109.65125.0786.2197.76
Other Operating Expenses
39.6429.6944.8440.5437.428.4
Operating Expenses
2,2361,9291,8341,7751,6091,468
Operating Income
810.8723.74588.93389.07376.45316.2
Interest Expense
-3.02-0.26-0.2-1.14-1.9-1.1
Interest & Investment Income
60.7459.0455.8786.6143.0357.89
Currency Exchange Gain (Loss)
-0-0-0.010-00
Other Non Operating Income (Expenses)
-2.44-0.18-1.69-1.75-1.77.08
EBT Excluding Unusual Items
866.08782.35642.9472.79415.88380.07
Impairment of Goodwill
------0.5
Gain (Loss) on Sale of Investments
4.44-0.010.125.930.05-0.05
Gain (Loss) on Sale of Assets
0.69-3.9-0.63-0.1-20.32-2.95
Asset Writedown
0.35--1.83---27.8
Other Unusual Items
48.4749.1312.4938.4217.7415.43
Pretax Income
920.03827.57653.04517.03413.35364.2
Income Tax Expense
117.81104.9984.9351.7350.8539.82
Earnings From Continuing Operations
802.21722.58568.12465.3362.5324.38
Minority Interest in Earnings
-2.6-0.03-0.01-0-0.961.11
Net Income
799.61722.55568.11465.3361.54325.49
Net Income to Common
799.61722.55568.11465.3361.54325.49
Net Income Growth
18.32%27.18%22.09%28.70%11.08%10.55%
Shares Outstanding (Basic)
566561561557556568
Shares Outstanding (Diluted)
570564566568567568
Shares Change (YoY)
1.46%-0.42%-0.30%0.26%-0.24%-1.22%
EPS (Basic)
1.411.291.010.840.650.57
EPS (Diluted)
1.401.281.000.820.640.57
EPS Growth
16.62%27.72%22.47%28.37%11.34%11.91%
Free Cash Flow
896.48760.75792.23807.92768.78378.71
Free Cash Flow Per Share
1.571.351.401.421.360.67
Dividend Per Share
0.9000.9000.8000.6000.5000.400
Dividend Growth
12.50%12.50%33.33%20.00%25.00%33.33%
Gross Margin
80.55%75.77%73.17%72.10%73.72%76.51%
Operating Margin
21.43%20.67%17.78%12.96%13.98%13.56%
Profit Margin
21.14%20.64%17.16%15.50%13.42%13.96%
Free Cash Flow Margin
23.70%21.73%23.92%26.91%28.54%16.24%
EBITDA
879.48795.48664.74463.4447.63384.66
EBITDA Margin
23.25%22.72%20.07%15.44%16.62%16.50%
D&A For EBITDA
68.6871.7475.8174.3371.1868.46
EBIT
810.8723.74588.93389.07376.45316.2
EBIT Margin
21.43%20.67%17.78%12.96%13.98%13.56%
Effective Tax Rate
12.80%12.69%13.00%10.01%12.30%10.93%
Revenue as Reported
3,7833,5013,3113,0022,6942,332
Advertising Expenses
-290.05265.07295.91-356.56
Source: S&P Global Market Intelligence. Standard template. Financial Sources.